PI
VIVO

PineBridge Investments’s Meridian Bioscience Inc VIVO Stock Holding History

PineBridge Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,633
Closed -$44K – 1203
2019
Q3 		$44K Buy
4,633
+1,767
+62% +$18.6K ﹤0.01% 1045
2019
Q2 		$34K Sell
2,866
-17,712
-86% -$213K ﹤0.01% 974
2019
Q1 		$363K Sell
20,578
-1,627
-7% -$27.1K 0.01% 763
2018
Q4 		$386K Sell
22,205
-2,689
-11% -$45.9K 0.01% 738
2018
Q3 		$371K Buy
24,894
+8,664
+53% +$134K 0.01% 797
2018
Q2 		$258K Sell
16,230
-819
-5% -$12.2K 0.01% 834
2018
Q1 		$242K Sell
17,049
-21,138
-55% -$313K 0.01% 860
2017
Q4 		$535K Buy
38,187
+32,950
+629% +$482K 0.01% 804
2017
Q3 		$75K Sell
5,237
-323
-6% -$4.62K ﹤0.01% 993
2017
Q2 		$87K Buy
5,560
+55
+1% +$792 ﹤0.01% 949
2017
Q1 		$75K Buy
5,505
+155
+3% +$2.17K ﹤0.01% 977
2016
Q4 		$94K Hold
5,350
– – ﹤0.01% 994
2016
Q3 		$104K Buy
5,350
+212
+4% +$4.15K ﹤0.01% 773
2016
Q2 		$100K Hold
5,138
– – 0.01% 763
2016
Q1 		$106K Sell
5,138
-479
-9% -$9.44K 0.01% 706
2015
Q4 		$116K Buy
5,617
+248
+5% +$4.75K 0.01% 716
2015
Q3 		$92K Buy
5,369
+504
+10% +$9.21K ﹤0.01% 783
2015
Q2 		$91K Sell
4,865
-6,009
-55% -$111K ﹤0.01% 783
2015
Q1 		$207K Buy
10,874
+1,583
+17% +$29.3K 0.01% 724
2014
Q4 		$153K Buy
9,291
+392
+4% +$6.72K 0.01% 800
2014
Q3 		$157K Buy
8,899
+2,474
+39% +$48.6K 0.01% 728
2014
Q2 		$132K Sell
6,425
-3,962
-38% -$81.4K 0.01% 702
2014
Q1 		$226K Sell
10,387
-974
-9% -$22.3K 0.01% 719
2013
Q4 		$301K Buy
11,361
+6,735
+146% +$166K 0.01% 638
2013
Q3 		$109K Hold
4,626
– – ﹤0.01% 693
2013
Q2 		$100K Buy
+4,626
New +$99.8K ﹤0.01% 699

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PineBridge Investments's VIVO Position: Q4 2019 in Review

PineBridge Investments sold out of Meridian Bioscience Inc (VIVO) in Q4 2019, closing a stake of 4,633 shares — an estimated $44K sold.

PineBridge Investments first reported a position in VIVO in Q2 2013 and held it in 26 quarters. The position peaked at $535K in Q4 2017. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2019.

  • PineBridge Investments reported no remaining Meridian Bioscience Inc position as of Q4 2019 after selling out during the quarter.
  • PineBridge Investments sold 4,633 Meridian Bioscience Inc shares in Q4 2019, an estimated $44K.
  • PineBridge Investments first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 26 quarters.
  • PineBridge Investments's Meridian Bioscience Inc position peaked at $535K in Q4 2017.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.